Clinical trial details
CF [, bronchiectasis
CYSTIC FIBROSIS, BRONCHIECTASIS
We used the BALF specimens from 12 months old infants with Cystic Fibrosis (CF) enrolled in the COMBAT-CF clinical trial. COMBAT-CF was a multi-centre, double-blinded, randomised, placebo-controlled study to evaluate the efficacy of azithromycin for the primary prevention of bronchiectasis in children with CF [